KYNB
KYNTRA BIO, INC.
NASDAQ · Healthcare · Medical - Pharmaceuticals · US
$4.05
−6.03%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 2.55x
Trailing multiples
Trailing twelve months
- P/E TTM
- 0.07x
- PEG TTM
- —
- Price / book
- -0.54x
- Price / sales
- 3.55x
- Price / cash flow
- -0.43x
Enterprise value
- Enterprise value
- -$52.9M
- EV / sales
- -11.46x
- EV / EBITDA
- 0.56x
- EV / EBIT
- 1.04x
- Market cap
- $16.4M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026